Ad is loading...
ADNRX vs RPMGX
ADNRX vs RPMGX Comparison
Open Charts ADNRX vs RPMGX
American Beacon ARK Transfmt Innov R6
Price$12.89
Change-$0.15 (-1.15%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth
Price$109.07
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
VS
VS
ADNRX vs RPMGX Comparison Chart
Loading...
ADNRX vs. RPMGX commentary
Sep 21, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Sell and RPMGX is a StrongBuy.
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 31.4B vs. ADNRX (195M). RPMGX pays higher dividends than ADNRX: RPMGX (0.05) vs ADNRX (0.00). ADNRX was incepted earlier than RPMGX: ADNRX (4 years) vs RPMGX (32 years). ADNRX is a more actively managed with annual turnover of: 33.00 vs. RPMGX (21.70). ADNRX has a lower initial minimum investment than RPMGX: ADNRX (0) vs RPMGX (2500). ADNRX annual gain was more profitable for investors over the last year : 11.89 vs. RPMGX (10.98).
| ADNRX | RPMGX | ADNRX / RPMGX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 4 years | 32 years | - |
| Gain YTD | -11.560 | 8.137 | -142% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 195M | 31.4B | 1% |
| Annual Yield % from dividends | 0.00 | 0.05 | - |
| Returns for 1 year | 11.89 | 10.98 | 108% |
| Returns for 3 years | -71.65 | -15.72 | 456% |
| Returns for 5 years | N/A | 13.58 | - |
| Returns for 10 years | N/A | 39.28 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...